ストックスクリーナーアプリを入手
22.95
1.60%
-0.43
アフターアワーズ：
22.95
前日終値:
$23.38
開ける：
$23.21
24時間の取引高:
724.59K
Relative Volume:
0.85
時価総額：
$1.14B
収益：
$290.38M
当期純損益:
$-21.03M
株価収益率:
-53.45
EPS:
-0.4294
ネットキャッシュフロー:
$-54.99M
1週間 パフォーマンス:
-4.03%
1か月 パフォーマンス:
-21.46%
6か月 パフォーマンス:
+20.82%
1年 パフォーマンス:
+19.82%
1日の値動き範囲:
$22.88
$23.82
1週間の範囲:
$22.88
$25.00
52週間の値動き範囲:
$15.59
$35.87
Staar Surgical Co Stock (STAA) Company Profile
Compare STAA vs ISRG, BDX, MDLN, ALC, RMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
STAA
Staar Surgical Co
|
22.95 | 1.16B | 290.38M | -21.03M | -54.99M | -0.4294 |
ISRG
Intuitive Surgical Inc
|
356.83 | 120.92B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
158.92 | 43.08B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
39.70 | 32.77B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
67.28 | 33.12B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
203.08 | 28.33B | 5.54B | 1.52B | 1.74B | 10.37 |
Staar Surgical Co Stock (STAA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-09 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2026-02-03 | 開始されました | Wedbush | Neutral |
| 2026-01-16 | 再開されました | Morgan Stanley | Underweight |
| 2025-04-21 | 開始されました | Wells Fargo | Equal Weight |
| 2025-02-12 | ダウングレード | BTIG Research | Buy → Neutral |
| 2025-02-12 | ダウングレード | Jefferies | Buy → Hold |
| 2025-02-12 | ダウングレード | Mizuho | Outperform → Neutral |
| 2025-02-12 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2024-07-15 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2024-06-11 | アップグレード | BTIG Research | Neutral → Buy |
| 2024-03-11 | アップグレード | Stifel | Hold → Buy |
| 2023-12-05 | ダウングレード | Needham | Buy → Hold |
| 2023-12-04 | 開始されました | Morgan Stanley | Equal-Weight |
| 2023-09-15 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2023-08-03 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2023-06-07 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2023-04-17 | 開始されました | Piper Sandler | Neutral |
| 2023-02-06 | ダウングレード | BTIG Research | Buy → Neutral |
| 2022-12-28 | 繰り返されました | BTIG Research | Buy |
| 2022-12-08 | 開始されました | Stifel | Hold |
| 2022-11-07 | アップグレード | Sidoti | Neutral → Buy |
| 2022-10-14 | 再開されました | Stephens | Overweight |
| 2022-10-13 | 開始されました | Mizuho | Buy |
| 2022-04-08 | 開始されました | Needham | Buy |
| 2022-03-28 | アップグレード | The Benchmark Company | Hold → Buy |
| 2022-03-18 | アップグレード | BTIG Research | Neutral → Buy |
| 2021-07-09 | 開始されました | Oppenheimer | Perform |
| 2021-01-19 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2020-10-26 | ダウングレード | Sidoti | Buy → Neutral |
| 2020-08-31 | アップグレード | Sidoti | Neutral → Buy |
| 2020-08-06 | 繰り返されました | The Benchmark Company | Buy |
| 2020-07-06 | ダウングレード | Sidoti | Buy → Neutral |
| 2020-06-24 | ダウングレード | BTIG Research | Buy → Neutral |
| 2020-06-15 | 開始されました | Jefferies | Buy |
| 2019-12-04 | 開始されました | BTIG Research | Buy |
| 2018-09-24 | 繰り返されました | The Benchmark Company | Buy |
| 2018-08-06 | 再開されました | The Benchmark Company | Buy |
| 2017-11-20 | 繰り返されました | The Benchmark Company | Buy |
| 2017-08-14 | 繰り返されました | The Benchmark Company | Buy |
| 2017-03-03 | 繰り返されました | The Benchmark Company | Buy |
| 2016-05-18 | アップグレード | The Benchmark Company | Hold → Buy |
| 2013-09-10 | 再開されました | The Benchmark Company | Buy |
| 2013-02-28 | 繰り返されました | The Benchmark Company | Buy |
| 2012-11-01 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2012-03-02 | 開始されました | Northland Securities | Outperform |
| 2011-10-25 | 繰り返されました | The Benchmark Company | Buy |
| 2010-10-12 | 開始されました | Morgan Joseph | Buy |
| 2010-05-11 | 開始されました | Benchmark | Buy |
すべてを表示
Staar Surgical Co (STAA) 最新ニュース
STAAR Surgical Co (STAA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
STAAR Surgical Co (STAA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
STAAR Surgical Co (STAA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
STAA|STAAR Surgical Co|Price:23.380|Chg%:-0.810 - TradingKey
STAAR Surgical Co (STAA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
STAAR Surgical (STAA) Is Down 16.5% After Doubling Q2 2026 Sales Guidance – Has The Bull Case Changed? - Yahoo Finance
STAA Reiterated by Wedbush -- Price Target Maintained at $40 - GuruFocus
A Look at Staar Surgical Co (STAA) After 9.3% Decline -- GF Value $32.05 vs Price $23.97 - GuruFocus
STAAR Surgical Shows Strong Preliminary Q2 Results, With Double-Digit Sales Growth in Americas - VisionMonday.com
STAAR Surgical (STAA) Stock Could Be 12% Undervalued On Q2 Sales Recovery - simplywall.st
Analysts Offer Insights on Healthcare Companies: Staar Surgical (STAA), Intuitive Surgical (ISRG) and Faeth Therapeutics (FTH) - The Globe and Mail
STAAR Surgical (STAA) Reports Strong Q2 Sales but Shares Drop - GuruFocus
STAAR Surgical (STAA) Shares Drop Despite Strong Q2 Revenue - GuruFocus
A Look at Staar Surgical Co (STAA) After 8.8% Decline -- GF Value $32.05 vs Price $26.44 - GuruFocus
Medical Device Stocks Decline Amid Insurance Changes - Intellectia AI
STAAR Surgical, Globus Medical, Integer Holdings, and Enovis Stocks Trade Down, What You Need To Know - Yahoo! Finance Canada
STAAR Surgical (STAA) Faces Significant Drop Despite Strong Q2 S - GuruFocus
STAA Stock On Track For Its Fourth Straight Session Of Gains – This Analyst Would Rather Be Early Than Late On Staar’s Growth Story - Stocktwits
Why is STAAR Surgical stock sliding today? By Investing.com - Investing.com South Africa
Caution Lingers for STAAR Surgical Amid Middle East Geopolitical Tensions - Benzinga
Staar Surgical China Turnaround Continues to Boost Confidence, Wedbush Says - 富途牛牛
Intuitive Surgical, Netflix And Other Big Stocks Moving Lower In Friday’s Pre-Market Session - Benzinga
Why is STAAR Surgical stock sliding today? - Investing.com UK
STAAR Surgical Q2 sales exceed $90 million led by Asia growth - scanx.trade
STAAR Surgical Q2 net sales more than double on growth in China, Asia-Pacific, Americas - Bitget
Staar Surgical Dips 8.4% After Hours on Early Q2 Results - Orange County Business Journal
Canaccord reiterates STAAR Surgical stock rating on Q2 revenue beat - Investing.com
Canaccord reiterates STAAR Surgical stock rating on Q2 revenue beat By Investing.com - Investing.com Canada
Staar Surgical (STAA) Reports Strong Q2 Sales Amid Regional Chal - GuruFocus
STAAR Surgical reports Q2 sales to exceed $90 million - Investing.com
STAAR Surgical reports Q2 sales to exceed $90 million By Investing.com - Investing.com Canada
STAAR Surgical Announces Preliminary Net Sales for Second Quarter 2026 - Business Wire
Analysts Are Bullish on Top Healthcare Stocks: Staar Surgical (STAA), Definium Therapeutics (DFTX) - The Globe and Mail
STAAR Surgical Co highlights its vision correction technology as investors weigh long-term growth - Ad-hoc-news.de
3 Reasons to Avoid STAA and 1 Stock to Buy Instead - Yahoo Finance
STAAR SURGICAL CO (STAA) Stock Chart - ChartMill
STAAR Surgical clears a key FDA milestone, shares in the medical device sector spotlight - ad-hoc-news.de
STAAR Surgical (STAA) Short Interest & Short Float | Updated Jun 2026 - MarketBeat
Form 4 STAAR Surgical Company For: 23 June By Investing.com - Investing.com Australia
5 must-read analyst questions from STAAR Surgical’s Q1 earnings call - MSN
Director of STAAR Surgical (NASDAQ: STAA) receives grant of 11,145 stock options - Stock Titan
Form 4 STAAR Surgical Company For: 22 June By Investing.com - Investing.com Nigeria
STAAR Surgical (STAA) director awarded 11,145 stock options at $29.12 strike - Stock Titan
Director Neal Bradsher granted 11,145 STAAR Surgical (STAA) stock options - Stock Titan
STAAR Surgical (NASDAQ: STAA) director adds shares and options in equity grants - Stock Titan
STAAR Surgical (STAA) adds 3.9M plan shares, elects board and ratifies BDO - Stock Titan
[Form 4] STAAR SURGICAL CO Insider Trading Activity - Stock Titan
STAAR Surgical (STAA) director Jiang Wei exercises RSUs and receives new grant - Stock Titan
Staar Surgical Co (STAA) 財務データ
収益
当期純利益
現金流量
EPS
Staar Surgical Co (STAA) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| SILVERMAN LOU | Director |
Jun 18 '26 |
Option Exercise |
0.00 |
10,683 |
0 |
11,158 |
| Jiang Wei | Director |
Jun 18 '26 |
Option Exercise |
0.00 |
10,683 |
0 |
77,127 |
| Foust Warren | Interim Co-CEO and Pres. & COO |
Mar 14 '26 |
Option Exercise |
0.00 |
29,325 |
0 |
63,588 |
| Foust Warren | Interim Co-CEO and Pres. & COO |
Mar 12 '26 |
Option Exercise |
0.00 |
8,175 |
0 |
34,263 |
| Michna Magda | Chief Development Officer |
Mar 14 '26 |
Option Exercise |
0.00 |
17,595 |
0 |
36,001 |
| Michna Magda | Chief Development Officer |
Mar 12 '26 |
Option Exercise |
0.00 |
6,178 |
0 |
20,622 |
| BROADWOOD PARTNERS, L.P. | Director |
Mar 13 '26 |
Buy |
18.61 |
316,017 |
5,882,656 |
16,123,842 |
| BROADWOOD PARTNERS, L.P. | Director |
Mar 12 '26 |
Buy |
18.12 |
299,432 |
5,424,330 |
15,807,825 |
| BROADWOOD PARTNERS, L.P. | Director |
Mar 11 '26 |
Buy |
17.52 |
54,764 |
959,558 |
15,508,393 |
| Jiang Wei | Director |
Jan 12 '26 |
Option Exercise |
0.00 |
20,967 |
0 |
66,444 |
0.62%
0.01%
大文字化:
|
ボリューム (24 時間):